Remove Events Remove Radiograph Remove Radiographer
article thumbnail

Phase 3 Study Shows Viability of 177Lu-PSMA-617 for Taxane-Naïve Metastatic Castration-Resistant Prostate Cancer

Diagnostic Imaging

The use of 177Lu-PSMA-617 was associated with a significantly longer radiographic progression-free survival and a 12 percent lower rate of grade 3 or higher adverse events in comparison to a change of ARPI therapy in patients with metastatic castration-resistant prostate cancer (mCRPC).

article thumbnail

Dozens of injuries trigger FDA recall of over 50,000 implantable tissue marking devices

Health Imaging

The Class I recall, which is the most serious recall the FDA issues, comes after numerous adverse events and complications linked to the radiographic markers were reported.

Insiders

Sign Up for our Newsletter

This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

Trending Sources

article thumbnail

International Day of Radiology to be held on November 8

AuntMinnie

On November 8, radiologists, radiographers, and radiological technologists will mark the tenth International Day of Radiology (IDoR 2023). Keep up with the latest details about the International Day of Radiology via its Facebook page.

article thumbnail

WHO to hold patient safety webinar on medical imaging

AuntMinnie

The World Health Organization (WHO) on September 17 will offer a webinar on the importance of accurate and timely diagnoses in ensuring patient safety that will include discussion of medical imaging and radiation exposure. to 1:30 p.m. to 1:30 p.m.

article thumbnail

Olympic challenge approaches for Paris MSK team

AuntMinnie

The first scans have been performed in the Olympic imaging polyclinic ahead of Friday's opening ceremony, and the 68-strong squad of radiologists and radiographers are primed and ready for action, according to musculoskeletal (MSK) expert Jérôme Renoux, MD. Bring it on!

X-ray 123
article thumbnail

Open Disclosure in Radiology

Everything Rad

How are radiographers treated when they admit to making a mistake? In other words: harm events, no harm events, and near miss events. A patient might slip and fall in the exam room; a radiographer might inadvertently touch or “catch” the patient with equipment. Are the processes for reporting well known?

article thumbnail

SNMMI: Lu-177 PSMA-617 shines for taxane-naive prostate cancer

AuntMinnie

Radiographic progression-free survival (rPFS) was the primary endpoint of the study, while overall survival was the key secondary endpoint. The most common groups of any-grade treatment-emergent adverse events in the Lu-177 PSMA-617 group were dry mouth and myelosuppression, resulting in anemia, thrombocytopenia, and neutropenia.